Join BOPA
Back to news articles

Join us at the Clinical Pharmacy Congress 2025 🗓️

By BOPA on 15th February 2025

BOPA are proud to announce our partnership with Clinical Pharmacy Congress London 2025, the UK’s largest bi-annual gathering of pharmacy professionals taking place for the 14th time on 9-10 May 2025, at Excel London.

Join us at the ExCel London this year as we will be presenting on the tremendous work our Immunotherapy Specialist Advisory Group have produced about Immunotherapy-related Toxicities!

BOPA have been granted free bursary places (worth £599 + VAT) for our members which will allow you access to this opportunity completely free!*

If you would like to take advantage of this limited free bursary scheme and join us in May for two days of gathering the brightest minds, cutting-edge innovations, and transformative ideas in clinical pharmacy under one roof. Simply use the link below and you will be granted free access – the sooner you do this, the better as there are only a limited number of free bursary places.

Register for you free place now.

For more info, click here.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article